JP7273987B2 - 腫瘍細胞群の特性を決定する方法、キット及びプログラム - Google Patents

腫瘍細胞群の特性を決定する方法、キット及びプログラム Download PDF

Info

Publication number
JP7273987B2
JP7273987B2 JP2021553884A JP2021553884A JP7273987B2 JP 7273987 B2 JP7273987 B2 JP 7273987B2 JP 2021553884 A JP2021553884 A JP 2021553884A JP 2021553884 A JP2021553884 A JP 2021553884A JP 7273987 B2 JP7273987 B2 JP 7273987B2
Authority
JP
Japan
Prior art keywords
breast cancer
drug
cancer cell
cells
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021553884A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021079522A1 (https=
Inventor
滋久 川田
美津子 石原
さえ子 猿渡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toshiba Corp
Original Assignee
Toshiba Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toshiba Corp filed Critical Toshiba Corp
Publication of JPWO2021079522A1 publication Critical patent/JPWO2021079522A1/ja
Application granted granted Critical
Publication of JP7273987B2 publication Critical patent/JP7273987B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2021553884A 2019-10-25 2019-10-25 腫瘍細胞群の特性を決定する方法、キット及びプログラム Active JP7273987B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2019/042047 WO2021079522A1 (ja) 2019-10-25 2019-10-25 腫瘍細胞群の特性を決定する方法、キット及びプログラム

Publications (2)

Publication Number Publication Date
JPWO2021079522A1 JPWO2021079522A1 (https=) 2021-04-29
JP7273987B2 true JP7273987B2 (ja) 2023-05-15

Family

ID=75620616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021553884A Active JP7273987B2 (ja) 2019-10-25 2019-10-25 腫瘍細胞群の特性を決定する方法、キット及びプログラム

Country Status (3)

Country Link
US (1) US20210404021A1 (https=)
JP (1) JP7273987B2 (https=)
WO (1) WO2021079522A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7585015B2 (ja) 2020-12-04 2024-11-18 株式会社東芝 核酸構築物のセット、キット、検出方法及び薬剤効果予測方法
JP7657583B2 (ja) 2020-12-16 2025-04-07 株式会社東芝 核酸構築物、キット、検出方法及び治療効果予測方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005525779A (ja) 2001-04-02 2005-09-02 バイエル アクチェンゲゼルシャフト 核酸構築物のトランスフェクションによって、身体サンプルから細胞を特異的に検出、単離および特徴付けするための方法
JP2013042721A (ja) 2011-08-25 2013-03-04 Toshiba Corp プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット
JP2015029461A (ja) 2013-08-02 2015-02-16 克昌 藤田 撮像装置
JP2015512507A (ja) 2012-03-14 2015-04-27 ソーク インスティテュート フォー バイオロジカル スタディーズ アデノウイルス腫瘍診断
JP2017127227A (ja) 2016-01-19 2017-07-27 東芝メディカルシステムズ株式会社 被検細胞の細胞特性を評価するためのレポーターベクター、アッセイキット、方法および装置
JP2017166910A (ja) 2016-03-15 2017-09-21 株式会社東芝 光学センサ、分析装置および分析方法
US20180305771A1 (en) 2017-04-19 2018-10-25 UNIVERSITé LAVAL Transcriptional system and uses thereof for single cell detection
WO2019176079A1 (ja) 2018-03-16 2019-09-19 株式会社 東芝 生分解性化合物、脂質粒子、脂質粒子を含む組成物、およびキット

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927754D0 (en) * 1989-12-08 1990-02-14 Image Research Ltd Improvements in and relating to light transfer systems and improved cell investigation techniques arising therefrom

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005525779A (ja) 2001-04-02 2005-09-02 バイエル アクチェンゲゼルシャフト 核酸構築物のトランスフェクションによって、身体サンプルから細胞を特異的に検出、単離および特徴付けするための方法
JP2013042721A (ja) 2011-08-25 2013-03-04 Toshiba Corp プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット
JP2015512507A (ja) 2012-03-14 2015-04-27 ソーク インスティテュート フォー バイオロジカル スタディーズ アデノウイルス腫瘍診断
JP2015029461A (ja) 2013-08-02 2015-02-16 克昌 藤田 撮像装置
JP2017127227A (ja) 2016-01-19 2017-07-27 東芝メディカルシステムズ株式会社 被検細胞の細胞特性を評価するためのレポーターベクター、アッセイキット、方法および装置
JP2017166910A (ja) 2016-03-15 2017-09-21 株式会社東芝 光学センサ、分析装置および分析方法
US20180305771A1 (en) 2017-04-19 2018-10-25 UNIVERSITé LAVAL Transcriptional system and uses thereof for single cell detection
WO2019176079A1 (ja) 2018-03-16 2019-09-19 株式会社 東芝 生分解性化合物、脂質粒子、脂質粒子を含む組成物、およびキット

Also Published As

Publication number Publication date
US20210404021A1 (en) 2021-12-30
JPWO2021079522A1 (https=) 2021-04-29
WO2021079522A1 (ja) 2021-04-29

Similar Documents

Publication Publication Date Title
Kislin et al. NHERF-1: modulator of glioblastoma cell migration and invasion
Nguyen et al. An immunogold single extracellular vesicular RNA and protein (AuSERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients
Zhao et al. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway
Li et al. PTBP1 promotes tumorigenesis by regulating apoptosis and cell cycle in colon cancer
Ito et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis
Zhang et al. Exosome miRNA-203 promotes M1 macrophage polarization and inhibits prostate cancer tumor progression
Lu et al. Evaluation of a new magnetic bead as an integrated platform for systematic CTC recognition, capture and clinical analysis
Wróblewska et al. MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression
JP7273987B2 (ja) 腫瘍細胞群の特性を決定する方法、キット及びプログラム
Zhou et al. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma
Schott et al. Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer
JP2023179455A (ja) Ｔａｓ１ｒ３タンパク質を発現する腫瘍に関する治療目的、診断目的及び／又は予後診断目的のマーカーとしてのｔａｓ１ｒ３タンパク質の使用
Feng et al. Simultaneous detection of two extracellular vesicle subpopulations in saliva assisting tumor T staging of oral squamous cell carcinoma
Leng et al. Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer
Li et al. RelB promotes the migration and invasion of prostate cancer DU145 cells via exosomal ICAM1 in vitro
Li et al. Colorectal cancer cells-derived exosomal miR-188-3p promotes liver metastasis by creating a pre-metastatic niche via activation of hepatic stellate cells
Yasodha et al. Exosomes from metastatic colon cancer cells drive the proliferation and migration of primary colon cancer through increased expression of cancer stem cell markers CD133 and DCLK1
SA111330026B1 (ar) أداة تشخيص ورم سرطاني استخدامتها
US20190317075A1 (en) INTERTUMORAL HOMOGENEITY DETERMINED BY MiCK ASSAY
CN105838820B (zh) 转录因子foxd1的新用途
CN114839377B (zh) 用于评估胆管癌进展的标志物及其应用
Fan et al. Carboxyl-terminal polypeptide fragment of MUC16 combing stathmin1 promotes gallbladder cancer cell migration and invasion
WO2020122102A1 (ja) 病変組織内への薬剤到達を予測する方法
CN111289749B (zh) C型1类尼曼-匹克蛋白检测物在制备筛查肝细胞癌产品中的应用
Reuter et al. Overexpression of MicroRNA-1 in Prostate Cancer Cells Modulates the Blood Vessel System of an In Vivo Hen's Egg Test–Chorioallantoic Membrane Model

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210701

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220628

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220829

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230313

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230404

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230428

R151 Written notification of patent or utility model registration

Ref document number: 7273987

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151